Literature DB >> 20123861

Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus.

Dalemari Crowther-Swanepoel1, Peter Broderick, Yussanne Ma, Lindsay Robertson, Alan M Pittman, Amy Price, Philip Twiss, Jayaram Vijayakrishnan, Mobshra Qureshi, Martin J S Dyer, Estella Matutes, Claire Dearden, Daniel Catovsky, Richard S Houlston.   

Abstract

A recent genome-wide association study of chronic lymphocytic leukaemia (CLL) has identified a susceptibility locus on 6p25.3 associated with a modest but highly significant increase in CLL risk. Using a set of single nucleotide polymorphism (SNP) markers, we generated a fine-scale map and narrowed the association signal to a 18 kb DNA segment within the 3'-untranslated region (UTR) of the IRF4 (interferon regulatory factor 4) gene. Resequencing this segment in European subjects identified 55 common polymorphisms, including 13 highly correlated candidate causal variants. In a large case-control study, it was shown that all but four variants could be excluded with 95% confidence. These four SNPs map to a 3 kb region of the 3'-UTR of IRF4, consistent with the causal basis of the association being mediated through differential IRF4 expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123861     DOI: 10.1093/hmg/ddq044

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  15 in total

1.  Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong.

Authors:  Qing Lan; Wing-Yan Au; Stephen Chanock; Jovic Tse; Kit-fai Wong; Min Shen; L P Siu; Jeff Yuenger; Meredith Yeager; Howard Dean Hosgood; Mark P Purdue; Raymond Liang; Nathaniel Rothman
Journal:  Eur J Haematol       Date:  2010-12       Impact factor: 2.997

Review 2.  Beyond GWASs: illuminating the dark road from association to function.

Authors:  Stacey L Edwards; Jonathan Beesley; Juliet D French; Alison M Dunning
Journal:  Am J Hum Genet       Date:  2013-11-07       Impact factor: 11.025

3.  B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Authors:  Daniela Asslaber; Yuan Qi; Nicole Maeding; Markus Steiner; Ursula Denk; Jan Philip Höpner; Tanja Nicole Hartmann; Nadja Zaborsky; Richard Greil; Alexander Egle
Journal:  Blood       Date:  2019-11-14       Impact factor: 22.113

4.  IRF4 and IRF8: Governing the virtues of B Lymphocytes.

Authors:  Vipul Shukla; Runqing Lu
Journal:  Front Biol (Beijing)       Date:  2014-08

5.  IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.

Authors:  Rossana Maffei; Stefania Fiorcari; Stefania Benatti; Claudio Giacinto Atene; Silvia Martinelli; Patrizia Zucchini; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

6.  Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans.

Authors:  Catherine C Coombs; Laura Z Rassenti; Lorenzo Falchi; Susan L Slager; Sara S Strom; Alessandra Ferrajoli; J Brice Weinberg; Thomas J Kipps; Mark C Lanasa
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

7.  Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.

Authors:  Shibin Ma; Vipul Shukla; Leilei Fang; Karen A Gould; Shantaram S Joshi; Runqing Lu
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

8.  Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future.

Authors:  Jennifer R Brown
Journal:  Ther Adv Hematol       Date:  2013-08

9.  A role for IRF4 in the development of CLL.

Authors:  Vipul Shukla; Shibin Ma; Richard R Hardy; Shantaram S Joshi; Runqing Lu
Journal:  Blood       Date:  2013-08-07       Impact factor: 22.113

Review 10.  Genomic approaches to chronic lymphocytic leukemia.

Authors:  Ma Reina Improgo; Jennifer R Brown
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.